Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania
Abstract Background Pharmacogenomics of hydroxyurea is an important aspect in the management of sickle cell disease (SCD), especially in the era of genomic medicine. Genetic variations in loci associated with HbF induction and drug metabolism are prime targets for hydroxyurea (HU) pharmacogenomics, ...
Saved in:
Main Authors: | Siana Nkya (Author), Collin Nzunda (Author), Emmanuel Saukiwa (Author), Frida Kaywanga (Author), Eliud Buberwa (Author), David Solomon (Author), Heavenlight Christopher (Author), Doreen Ngowi (Author), Julieth Johansen (Author), Florence Urio (Author), Josephine Mgaya (Author), Salman Karim (Author), Mohamed Zahir Alimohamed (Author), Raphael Z. Sangeda (Author), Clara Chamba (Author), Emile R. Chimusa (Author), Enrico Novelli (Author), Julie Makani (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania
by: Siana Nkya, et al.
Published: (2020) -
Building research capacity for sickle cell disease in Africa: Lessons and challenges from establishing a birth cohort in Tanzania
by: Siana Nkya, et al.
Published: (2022) -
Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania
by: Upendo Masamu, et al.
Published: (2020) -
Hydroxyurea-induced melanonychia
by: Michael G. Buontempo, BS, et al.
Published: (2023) -
Perspectives on Building Sustainable Newborn Screening Programs for Sickle Cell Disease: Experience from Tanzania
by: Daima Bukini, et al.
Published: (2021)